Maravai Lifesciences Holdings (MRVI) Gross Profit (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Gross Profit of $33.7 million for Q1 2026, up 336.26% year-over-year from $7.7 million in Q1 2025, and up 162.43% quarter-over-quarter from $12.8 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Gross Profit (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Gross Profit history runs 7 years deep, the most recent figure standing at $33.7 million for Q1 2026.
- In Q1 2026, Gross Profit rose 336.26% year-over-year to $33.7 million; the TTM figure through Mar 2026 stood at $60.0 million (down 33.51% YoY), while the FY2025 annual figure was $34.0 million, down 68.62% from the prior year.
- Gross Profit for Q1 2026 stood at $33.7 million, up from $12.8 million in the prior quarter.
- The five-year high for Gross Profit was $205.2 million in Q2 2022, with the low at $5.7 million in Q3 2025.
- The 5-year median for Gross Profit is $30.8 million (2024), against an average of $60.6 million.
- The sharpest annual moves came in 2023 and 2026: Gross Profit plunged 87.51% in 2023, then surged 336.26% in 2026.
- Maravai Lifesciences Holdings' Gross Profit stood at $151.5 million in 2022, then sank by 74.23% to $39.0 million in 2023, then tumbled by 50.32% to $19.4 million in 2024, then plunged by 33.77% to $12.8 million in 2025, then jumped by 162.43% to $33.7 million in 2026.
- Business Quant data shows MRVI's Gross Profit at $33.7 million in Q1 2026, $12.8 million in Q4 2025, and $5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.65 Mn |
| Jun 30, 2026 | 20.65 Mn |
| Mar 31, 2026 | 33.70 Mn |
| Mar 31, 2026 | 33.70 Mn |
| Dec 31, 2025 | 12.84 Mn |
| Dec 31, 2025 | 12.84 Mn |
| Sep 30, 2025 | 5.66 Mn |
| Sep 30, 2025 | 5.66 Mn |
| Jun 30, 2025 | 7.77 Mn |
| Jun 30, 2025 | 7.77 Mn |
| Mar 31, 2025 | 7.73 Mn |
| Mar 31, 2025 | 7.73 Mn |
| Dec 31, 2024 | 19.39 Mn |
| Dec 31, 2024 | 19.39 Mn |
| Sep 30, 2024 | 32.23 Mn |
| Sep 30, 2024 | 32.23 Mn |
| Jun 30, 2024 | 30.84 Mn |
| Jun 30, 2024 | 30.84 Mn |
| Mar 31, 2024 | 25.84 Mn |
| Mar 31, 2024 | 25.84 Mn |